Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifepristone plus misoprostol versus misoprostol alone for early pregnancy failure
NL-OMON21883Phase 4Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of mifepristone and misoprostol in Pregnancy loss, sponsored by Radboud University Medical Center. Started Oct 2016; status: active, not recruiting.
02
Drugs
mifepristonemisoprostol
03
Conditions
Pregnancy loss
Beyond the preview
Go deeper on NL-OMON21883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21883.